NYSEAMEX:PBTH Investor Files Lawsuit Against Takeover of PROLOR Biotech
An investor, who holds NYSEAMEX:PBTH shares, filed a lawsuit in effort to stop the proposed takeover of PROLOR Biotech Inc by OPKO Health, Inc.to acquire for approximately $7.00 per NYSEAMEX:PBTH share.
View full press release